The strongly aromatic Australian desert species Eremophila dalyana is an Aboriginal medicinal plant that continues to be used today in Central Australia in the treatment of respiratory complaints and Sarcoptes scabiei infestation. Using hydrodistillation of aerial parts of the plant, the new natural product myodesert-1ene was isolated in two disjunct populations at up to 98% of the volatiles present in the hydrodistilled oils. Weak antimicrobial activities were observed for whole oils and myodesert-1-ene. Activities in the hydrodistilled oil were attributed to the antimicrobial sesquiterpenes elemol and eudesmol which showed good activity when isolated and were relatively abundant in the chemotype used medicinally. The biogenesis of myodesert-1-ene from iridodial is proposed.
Eremophila dalyana F.Muell. (Schrophulariaceae) is an aromatic shrub popular with the Eastern Arrernte and Alyawarr peoples of Central Australia for the treatment of colds and other chest infections and to treat Sarcoptes scabiei infestation [1] . The plant is regarded as rare in the Northern Territory (NT), occurring only in and around the Dulcie Ranges among the Gidgee shrubs (Acacia cambagei: Fabaceae). E. dalyana is also widely distributed in mid to south-west Queensland (Qld) although there are no ethnopharmacological records relating to the specimens endemic to Qld which may be due to chemotypic variation [1a,b] . In an earlier study, elemol, and -eudesmol, a new furo [2,3-c] furan lignan (epieudesmin) and an unidentified terpene were isolated from a specimen of E. dalyana collected from the Dulcie Ranges in the NT [2] . Wider sampling of the species has not been reported and so it is not known whether the disjunct populations exhibit similar chemistry. The current study focuses on isolation and identification of the components in the solvent extracts and the hydrodistilled oils of E. dalyana and the antimicrobial activities of oils and extracts from both disjunct populations.
To survey E. dalyana phytochemistry, aerial parts were collected from two populations, one from south-west Qld in the 'gray ranges' north of Thargomindah (Postcode: 4492) and the other from cultivated specimens originally of Dulcie Ranges provenance, now situated at the Alice Springs Desert Park. (See supplementary data for Figure showing specimen locations). In the current study, specimens originally of Dulcie Ranges (NT) provenance are denoted as NT1, NT2 and NT3 and those of Qld provenance are QLD1, QLD2 and QLD3. Solvent extracts (NT1S and QLD1S) of the specimens as well as hydrodistilled oils (NT1-3 and QLD1-3) were examined by GCMS and the identified components are shown in Table 1 .
In the specimens collected from both the NT and Qld the major component was myodesert-1-ene (1, Scheme 1). As a percentage of the hydrodistilled oil and CH 2 Cl 2 extracts, it was much higher in the Qld specimens and accounted for up to 98% of the volatiles detected by GCMS in selected specimens (Table 1) . Elemol and eucalyptol were also present as major components in oils from the NT samples, and in one specimen elemol concentration eclipsed that of 1, providing evidence of geographically separated chemotypes. These chemotypic differences were also present in the CH 2 Cl 2 extracts (NT2S and QLD1S) although the variation was not as pronounced.
Compound 1 has previously been generated during the characterization of the natural product methoxymyodesert-3-ene (2) The spectra was taken immediately after dissolving 3 in CDCl3 as the elimination reaction forming 1 occurs quickly. The spectra of 3 in C 6 D 6 is provided in the supplementary data due to enhanced stability.
1 H NMR include two methyl doublets assigned as C8 and C9 at  0.93 and 1.01 ppm respectively, a vinylic proton assigned as C1 at  6.16 ppm and the C3 methylene with attached heteroatom at  3.33 and 3.89 ppm. The 3- proton exhibited a transdiaxial coupling with H-4. Coupling around the dihydropyran ring was consistent with the energy minimized half chair conformation obtained using density functional theory at the B3LYP/631-G(d) [5] level shown at the top of Table 2 .
The 13 C and 1 H NMR data for 1 gave an excellent match for the low field NMR previously reported by Grant et al. [4a] . The previous semi-synthesis of 3 used a hydrogenation of the enol ether in 2a which installed the C-4 stereocentre. As the stereochemical assignment of the product relied upon a fairly complex argument, we decided to independently verify the stereochemistry of 2, adapting the synthesis to re-examine the intermediates formed (Scheme 1). Thus, 2a, which is readily available from E. deserti [4a] , was hydrogenated using Pt/C to furnish 3 and 4 which were separated by flash chromatography. The two isomers 3 and 4 were ring-flipped relative to one another and had chair conformations in the 6-membered ring which allowed for confirmation of the stereochemistry of C-4 using the coupling constants at the C-3 methylene group and the orientation of the methoxy group at C-1. When the major isomer 3 was dissolved in CDCl 3 , immediate formation of the natural product 1 was seen due to trace acid present in the solvent and it was possible to drive the reaction to completion by heating in the presence of phthalic acid. A similar elimination was observed in the epimer 4, however, the NMR data for the eliminated enol ether was not consistent with the natural product. Considered together, these results confirm the stereochemistry reported by Grant et al. [4a] .
The ready elimination of the methoxy group at the anomeric centre of 3 allows us to speculate on the biosynthetic origins of 1. The biosynthetis of the related iridoids 2a and 2b in E. deserti has previously been proposed by Sutherland and Park [6] , however recent evidence [7] suggests a modified pathway is responsible for iridodial 6 and hence this class of iridoid (Scheme 2).
This process begins with 8-oxogeranial 5 which undergoes an intramolecular reductive cyclization to give dial 6 [7] .
Scheme 1: Preparation of 1 from methoxymyodesert-3-ene 2a.
Methoxymyodesert-3-ene 2a presumably derives from the dial 6 by enolization and cyclization to give the hemiacetal 7 followed by methylation. Acetylation of 7 will lead to (1S)-1-acetoxymyodesert-3-ene 2b and the (1R)-stereoisomer. This same iridodial 6 may well be the precursor of 1 in E. dalyana. A reduction of the iridodial 6 to the corresponding alcohol 8 followed by cyclization would yield a hemiacetal 9 similar to semisynthetic intermediate 3 which has been shown to undergo rapid dehydration. An analogous elimination of the hemiacetal 9 would yield myodesert-1-ene 1. Even though the natural product was obtained by hydrodistillation, the possibility that 1 is an artifact formed during the isolation process can be eliminated. The isolated natural product has a characteristic odour which is also present in the leaves, and a CH 2 Cl 2 extract of the plant unequivocally demonstrated the presence of 2 without heating (Table 1) .
Scheme 2:
Proposed biosynthesis of myodesert-1-ene 1.
Traditional therapeutic use employed a combination of topical applications (mainly to the chest) and inhalation (application under the nose). Antimicrobial activity is a critical consideration in the context of traditional use of extracts to treat chest infections and so we have determined MIC values for a series of microorganisms (Table 3 ). In the current study 1 demonstrated little antimicrobial activity, however, the crude oils were more active which was attributed to the minor component sesquiterpene alcohols elemol and eudesmol. When a purified mixture of elemol and eudesmol from the extract was assayed, good activity was observed against S. aureus (20 g/mL) and B. subtilis (1 g/mL) which supported this conclusion. Furthermore, elemol and nepetalactone which were identified in the NT1-3 extracts have previously been shown to have strong repellant activity against two common species of tick which may support the traditional use of this plant to treat Sarcoptes scabiei [8] .
The observation of 1 in the hydrodistilled oils of E. dalyana represents the first reported occurrence of this compound in nature.
Incredibly, this compound was present at concentrations up to 98% of the hydrodistilled oils which were obtained at ~1% w/w from the Qld specimens and 1 was a significant proportion of solvent extracts. It is likely that elemol, nepetalactone and 1 is present in extracts produced in the course of therapeutic use by the Aboriginal peoples, however, the current study has not identified any specific biological activities related to 1.
Essential oil and terpenoids from Eremophila dalyana Natural Product Communications Vol. 11 (9) 2016 1213 EE: Elemol and Eudesmol isomers (γ-, β-, α-) at 5:1:1:1. Positive control was tetracycline except for C. albicans, where nystatin was used.
Experimental
General: GC-MS analyses were performed using an Agilent Technologies 7890A GC-System coupled with an Agilent 5975C mass selective detector (triple-Axis detector). Separation of 1 µL injections used a HP-5MS Agilent column (30 m × 250 µm × 0.25 µm). Operating conditions were as follows; injector split ratio 25:1, temperature 250˚C, carrier gas helium, 1.0mL/min, constant flow. Column temperature, 50˚C (no hold), 5˚C per minute then @ 280˚C hold 5 min. MS acquired at -70 eV using a mass scan range of 30-400 m/z. NMR was performed using a 500 MHz Avance III Bruker spectrometer. 1 H NMR spectra were referenced to TMS ( 0.00 ppm) and 13 C NMR spectra were referenced to CDCl 3 ( 77.0 ppm). Reagents were purchased from Sigma-Aldrich
Plant extracts and hydrodistilled oils:
Voucher specimens were lodged either at the Alice Springs Herbarium or the N.C.W Beadle Herbarium at the University of New England Armidale (NSW, Aus). Herbarium vouchers in respective order are; A0101444 (NT1, NT2, NT3) and NE 101934 (QLD1, QLD2, QLD3). All plants were collected with permission of the appropriate governmental authority (NT Permit: 51404; Qld Permit: (WISP10799812). Hydrodistilled oils were produced using a previously described method [9] . Specimens NT1, NT2 and NT3 were hydrodistilled for 2 h, 3 h and 4 h, respectively. All other specimens were hydrodistilled for 3-4 hr. Plant leaves were extracted in dichloromethane (CH 2 Cl 2 ) by soaking 5 g of aerial parts in CH 2 Cl 2 (30 mL) for 24 h. GCMS analysis was as previously described [9] . Elemol [10] , cis,cisnepetalactone [11] and (1R)-1-acetoxymyodesert-3-ene [4b] structures were confirmed by 1 H and 13 C NMR on isolated material.
Myodesert-1-ene (1):
The crude hydrodistilled oil from extract QLD2 (1.0 g) was purified by flash chromatography (EtOAc/hexanes 10:90) to yield myodesert-1-ene (2) as a colourless oil (948 mg, 95% (1) from (3) : The hydrogenated acetal 3 (100 mg, 0.54 mmol) was refluxed in water (5 mL) containing phthalic acid (9 mg, 0.05 mmol) for 4 h. The reaction mixture was washed with 20 mL of saturated NaHCO 3 then the aqueous phase extracted with Et 2 O (3 x 15 mL). The organic layers were collected, dried (MgSO 4 ) and then concentrated to yield myodesert-1-ene, 1 (15 mg, 18%).
Preparation of

Antimicrobial assays:
Working stocks of all target species were maintained on Nutrient Agar (NA) with the exception of Candida albicans which required Yeast Extract Peptone Agar (YEPA). All growth media were purchased from Oxoid (Thebarton, South Australia) and prepared according to the manufacturer's instructions. Target species in the current study are Staphylococcus aureus (ATCC 29213), S. epidermidis (ATCC 12228), Salmonella typhimurium (ACM 3598), Escherichia coli (ATCC 25922), Bacillus subtilis (UNE stock) and Candida albicans (ATCC 10231). Minimum inhibitory concentrations (MIC) of the oils and extracts were determined using a micro-titre plate two-fold broth dilution method [12] with the following modifications. Emulsions of oil were prepared in broth (Tryptone Soya for bacteria; YEPA for yeast) with 0.15% w/w agar [13] . Inoculum was standardized to match a 0.5 McFarland Turbidity Standard [14] . Inoculum was further diluted to achieve 5 × 10 5 cfu per well. Following inoculation, the 96-well plates were sealed using parafilm and placed into an incubator at 37˚C for approximately 20 h before dispensing 40 µL of sterile 0.2 mg/mL p-iodonitrotetrazolium dye and examining for colour changes. Metabolism of the dye giving a coloured solution indicated organism growth. Positive inhibition controls included tetracycline for bacterial growth and nystatin for C. albicans. Experiments were repeated 3 or more times and the results are reported in μg/mL as an average of replicates where results were below 3 mg/mL. Supplementary data: 1 H and 13 C NMR data for 1 and 3 and distribution maps for the two disjunct populations are available as supplementary data.
